Physician

Bruce Allan Benedick, M.D.

According to 2025 Medicare claims, Bruce Benedick, M.D. (NPI: 1346274602) practices interventional cardiology in the San Francisco-San Mateo-Redwood City, CA market, with the plurality of this provider's patient population coming from San Mateo, CA. This provider's primary affiliated billing organization is SUTTER BAY MEDICAL FOUNDATION (NPI: 1013950807; TIN: 941156581) and primary practice location at 94303-2228. Benedick is affiliated with the Sutter Medicare Direct (ACO ID: A5279), participating under the MSSP model.

Benedick's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,846 traditional Medicare patients, billed 7,052 HCPCS/CPT codes, and received $822,988 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 9,697 prescription claims across 1,081 beneficiaries totaling $2,570,293 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 1 records totaling $25. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $619,730 to $2,570,293. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	975	6,548	$902,671
2016	1,013	6,537	$769,550
2017	1,047	6,785	$802,276
2018	1,104	7,139	$788,221
2019	1,062	7,291	$900,686
2020	976	6,222	$752,827
2021	1,458	6,244	$889,801
2022	1,718	6,079	$826,031
2023	1,856	5,923	$860,233
2024	1,846	7,052	$822,988

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	527	4,748	$619,730
2016	579	4,959	$728,186
2017	650	5,302	$733,026
2018	717	5,972	$823,402
2019	776	6,326	$917,697
2020	781	7,166	$1,273,752
2021	822	7,714	$1,598,176
2022	958	8,365	$2,039,847
2023	1,046	9,506	$2,612,662
2024	1,081	9,697	$2,570,293

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	761	793	$186
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	821	1,109	$155
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	458	484	$122
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	820	1,013	$15
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	632	969	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	630	49,286	$937,040
Jardiance	Empagliflozin	529	41,960	$790,532
Entresto	Sacubitril/Valsartan	169	12,841	$279,632
Repatha Sureclick	Evolocumab	101	7,170	$137,257
Multaq	Dronedarone Hcl	39	2,610	$66,679

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$25	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bruce Allan Benedick, M.D.?

Tedicare shows public-source Medicare data for Bruce Allan Benedick, M.D. (NPI 1346274602), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bruce Allan Benedick, M.D. have ACO affiliation data?

Bruce Allan Benedick, M.D. is shown with ACO affiliation data for Sutter Medicare Direct (MSSP, ACO ID A5279).

What billing organization is linked to Bruce Allan Benedick, M.D.?

Bruce Allan Benedick, M.D. is linked to SUTTER BAY MEDICAL FOUNDATION (billing NPI 1013950807) in the available physician profile data.

Does Bruce Allan Benedick, M.D. have Open Payments data?

Bruce Allan Benedick, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.